Cancer patients can seek the expert advice of oncologists in Singapore and the region in real-time, via a new specialist telemedicine platform
16 July 2020, Singapore – Singapore medical start-up Oncoshot is partnering with digital healthcare provider MyDoc, to give cancer patients access to second opinion advice from leading oncologists. MyDoc will direct patients from within its network to Oncoshot’s specialist telemedicine platform, which offers remote medical advice from highly qualified oncologists as well as a clinical trial matching solution.
The service enables patients from the region to make informed decisions about cancer care, with the aim of expanding their treatment options and improving clinical outcomes. Cancer, the second leading cause of mortality worldwide, is rising in prevalence in Singapore. According to the Singapore Cancer Registry, one in four people in Singapore may develop cancer in their lifetime, and the number of people living with cancer will continue to increase.
However, with cancer care advancing at an unprecedented rate globally, cancer patients today can choose from a wellspring of treatment options with the potential to elevate their quality of life. Seeking a second opinion to complement their primary healthcare providers can provide them with reassurance on their diagnosis and expose them to a range of therapies.
“Through this partnership, more cancer patients will be able to tap into medical advice from leading private sector cancer care providers from Singapore and the region, and connect to clinical trials on cancer treatments through telemedicine services,” said Dr Huren Sivaraj, Oncoshot CEO and co-founder, who is a medical oncologist at National Cancer Centre Singapore.
“As the world continues to cope with the Covid-19 pandemic and travel remains a challenge, it is important for cancer patients to have easy and timely access to medical advice that allows for informed decision making. The Oncoshot platform gives patients and oncologists efficient access to all critical information relevant to each individual patient’s unique medical condition,” added Dr Sivaraj.
“For many patients, getting diagnosed with cancer is a nerve-wracking experience. It’s a complicated illness that requires long term treatment and care, which is a difficult process for not just the patients, but also their families. Having the ability to conveniently get as much information as you can, from a platform like Oncoshot that provides specialists consultations and second opinions will be valuable. MyDoc will add local medical services in each of the regional countries to provide a supportive ecosystem for cancer patients. This is an important segment for us going forward,” said Dr Vas Metupalle, Chief Information Officer and Co-founder, MyDoc.
Besides second opinion advice, Oncoshot swiftly connects patients with institutes around the world that are running clinical trials, through Artificial Intelligence technology. The medical start-up, along with partners including the Singapore Clinical Research Institute, is building South-east Asia’s first ecosystem for cancer clinical trials and treatment options.
###
About Oncoshot
Oncoshot helps patients, caregivers and oncologists in a fast-changing landscape of cancer care identify cancer clinical trials more efficiently and effectively. Its mission is to empower patients to take control of their treatment journey and expand their options, thus improving their quality of life. The Oncoshot platform allows patients to share their data with institutes conducting clinical trials and receive a swift response, shortening the search from weeks to minutes by leveraging Artificial Intelligence technology. The technology platform also supports Project Enhanced Clinical Trial Initiation, Screening and Enrolment (EISE; http://www.eise.sg), a national clinical trial ecosystem. A private company headquartered in Singapore, Oncoshot is recognised by the Singapore Ministry of Health and Health Sciences Authority Singapore as a digital health company. For more information, please visit http://www.oncoshot.com.
About MyDoc
MyDoc is a digital healthcare platform that delivers the right care at the right time. Combining the latest in healthcare technologies and a GP-led coordinated care clinical triage, MyDoc continuously steers patients onto personal care pathways that lead to better health outcomes at lower costs.
Through MyDoc, employees and their dependents stay connected with a team of licensed allied healthcare professionals. Patients covered by corporate and personal healthcare plans from six of the largest health insurers in the region enjoy a convenient cashless care journey.
Established in 2012, MyDoc’s integrated online-offline ecosystem is used by employees of over 200 Fortune 500 companies and insurance policyholders across eight markets in Asia. MyDoc is part of the Singapore Ministry of Health sandbox and is backed by UST Global, a Temasek-backed global B2B technology provider.
Recently, MyDoc was recognised by Frost and Sullivan as 2020 Singapore Telehealth Company of the Year.
Media Contact
MyDoc: media@my-doc.com
Oncoshot: Florence Fang
Flame Communications
Email: florence.fang@flamecomms.com
Tel: (65) 8811 9396
